Mechanisms of Piperacillin/Tazobactam Nephrotoxicity: Piperacillin/Tazobactam-Induced Direct Tubular Damage in Mice

被引:2
|
作者
Yang, Jihyun [1 ]
Ko, Yoon Sook [2 ]
Lee, Hee Young [2 ]
Fang, Yina [2 ]
Oh, Se Won [2 ]
Kim, Myung-Gyu [2 ]
Cho, Won Yong [2 ]
Jo, Sang-Kyung [2 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med,Div Nephrol, Seoul 03181, South Korea
[2] Korea Univ, Anam Hosp, Dept Internal Med, Seoul 02841, South Korea
来源
ANTIBIOTICS-BASEL | 2023年 / 12卷 / 07期
关键词
nephrotoxicity; piperacillin; tazobactam; mitochondria; ACUTE KIDNEY INJURY; VANCOMYCIN; TAZOBACTAM; COMBINATION; CEFEPIME;
D O I
10.3390/antibiotics12071121
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Piperacillin/tazobactam (PT) is one of the most commonly prescribed antibiotics for critically ill patients in intensive care. PT has been reported to cause direct nephrotoxicity; however, the underlying mechanisms remain unknown. We investigated the mechanisms underlying PT nephrotoxicity using a mouse model. The kidneys and sera were collected 24 h after PT injection. Serum blood urea nitrogen (BUN), creatinine, neutrophil gelatinase-associated lipocalin (NGAL), and renal pathologies, including inflammation, oxidative stress, mitochondrial damage, and apoptosis, were examined. Serum BUN, creatinine, and NGAL levels significantly increased in PT-treated mice. We observed increased IGFBP7, KIM-1, and NGAL expression in kidney tubules. Markers of oxidative stress, including 8-OHdG and superoxide dismutase, also showed a significant increase, accompanied by mitochondrial damage and apoptosis. The decrease in the acyl-coA oxidase 2 and Bcl2/Bax ratio also supports that PT induces mitochondrial injury. An in vitro study using HK-2 cells also demonstrated mitochondrial membrane potential loss, indicating that PT induces mitochondrial damage. PT appears to exert direct nephrotoxicity, which is associated with oxidative stress and mitochondrial damage in the kidney tubular cells. Given that PT alone or in combination with vancomycin is the most commonly prescribed antibiotic in patients at high risk of acute kidney injury, caution should be exercised.
引用
收藏
页数:14
相关论文
共 50 条
  • [22] Piperacillin/tazobactam-induced neutropenia, thrombocytopenia, and fever during treatment of a diabetic foot infection
    Uzun, Gunalp
    Onem, Yalcin
    Hatipoglu, Mustafa
    Turhan, Vedat
    Mutluoglu, Mesut
    Ay, Hakan
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2013, 45 (01) : 73 - 76
  • [23] Piperacillin/tazobactam-induced sudden severe thrombocytopenia in a patient with a pressure ulcer: a case report
    Roh, Solji
    Hashimoto, Kohei
    Kiriishi, Rina
    Matsubara, Ken
    Isozaki, Yuki
    Tanaka, Hiroaki
    Kuwata, Tomoyuki
    JOURNAL OF WOUND CARE, 2024, 33 : S25 - S30
  • [24] Piperacillin/tazobactam-induced coagulopathy in a patient through a vitamin K-dependent mechanism
    Yu, Zhenwei
    Chen, Huadong
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021, 28 (04) : 237 - 238
  • [25] Impact of combining vancomycin with piperacillin/tazobactam or with meropenem on vancomycin-induced nephrotoxicity
    R. F. Tookhi
    N. A. Kabli
    M. A. Huntul
    A. K. Thabit
    Internal and Emergency Medicine, 2021, 16 : 975 - 979
  • [26] Impact of combining vancomycin with piperacillin/tazobactam or with meropenem on vancomycin-induced nephrotoxicity
    Tookhi, R. F.
    Kabli, N. A.
    Huntul, M. A.
    Thabit, A. K.
    INTERNAL AND EMERGENCY MEDICINE, 2021, 16 (04) : 975 - 979
  • [28] Dress induced by piperacillin-tazobactam in a child
    Gonzalez Diaz, Carlos
    Gonzalez Hermosa, Andres
    Garcia-Lirio, Eduardo
    Martinez-Aranguren, Ruben
    Gamboa Setien, Pedro
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2015, 3 (04): : 615 - 617
  • [29] Vancomycin/Piperacillin-tazobactam Nephrotoxicity in the Critically Ill Reply
    Schreier, Diana J.
    Rule, Andrew D.
    Barreto, Erin F.
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (07) : 1521 - 1521
  • [30] Criteria for comparison of the combinations piperacillin/tazobactam and piperacillin/sulbactam [Kriterien zur abgrenzung der kombinationen piperacillin/tazobactam und piperacillin/sulbactam]
    Heizmann W.R.
    Derendorf H.
    Zeitschrift für Herz-,Thorax- und Gefäßchirurgie, 2005, 19 (2) : 89 - 99